Brief: Eledon Pharmaceuticals Inc Files For Mixed Shelf Of Up To $250 Million – SEC Filing
20/09/2024 21:22
Sept 20 (Reuters) - Eledon Pharmaceuticals Inc ELDN.O :
* ELEDON PHARMACEUTICALS INC FILES FOR MIXED SHELF OF UP TO
$250
MILLION – SEC FILING
* ELEDON PHARMACEUTICALS - SALES AGREEMENT PROSPECTUS
COVERING
OFFERING OF UP TO $75 MILLION COMMON STOCK THAT MAY BE ISSUED
UNDER SALES AGREEMENT
Source text for Eikon: ID:n0001193125-24-222880
Further company coverage: ELDN.O
(Reuters.Briefs@thomsonreuters.com)
Recent news on Eledon Pharmaceuticals
See all newsBrief: Eledon Presents Updated Long-Term Phase 2 Bestow Extension Study Results At The International Congress Of The Transplantation Society
Eledon Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Eledon Pharmaceuticals Q2 net loss widens on warrant liability changes
Eledon Pharmaceuticals Inc expected to post a loss of 16 cents a share - Earnings Preview
Brief: Natera And Eledon Announce Strategic Partnership For Prospera™ Monitoring In Planned Phase 3 Kidney Transplant Trial